ESMO - European Society for Medical Oncology
Carlos Gomez-Roca, MD, PhDs is an experienced Head of the Early Phase Unit at INSTITUT CLAUDIUS REGAUD, specializing in bringing new treatments to patients through drug development. Carlos is also a Medecin Specialiste de CLCC at the same company and a member of the ESMO Faculty - MCBS Extended Work Group at ESMO, focusing on evaluating the impact of new drugs on cancer patients. Prior to this, Carlos worked at Institut Gustave Roussy, with a focus on drug development for gastrointestinal tumors and lung cancer. Carlos holds multiple degrees in medical oncology, immunology, cancer, and internal medicine from various universities.
This person is not in any offices
ESMO - European Society for Medical Oncology
1 followers
Representing more than 32,000 oncology professionals from 170 countries worldwide, ESMO is a reference for oncology education and information. Driven by a shared determination to secure the best possible outcomes for patients, ESMO is committed to standing by those who care about cancer through addressing the diverse needs of #ONEoncologycommunity, offering #educationforLIFE, and advocating for #accessiblecancerCARE.